Simultaneous MFN2 and GDAP1 mutations cause major mitochondrial defects in a patient with CMT
Authors:
- C. CasasnovasCCC. Casasnovas
- N. GueguenNGN. Gueguen
- M.-C. MalingeMMM.-C. Malinge
- V. GuilletVGV. Guillet
- P. ReynierPRP. Reynier
- D. BonneauDBD. Bonneau
- P. Amati-BonneauPAP. Amati-Bonneau
- I. BanchsIBI. Banchs
- V. VolpiniVVV. Volpini
- V. ProcaccioVPV. Procaccio
- A. ChevrollierACA. Chevrollier
- 26 April 2011
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 76 (17) , 1524-1526
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Mitochondrial dysfunction and pathophysiology of Charcot–Marie–Tooth disease involving GDAP1 mutationsExperimental Neurology, 2011
- Phenotypic spectrum of MFN2 mutations in the Spanish populationJournal of Medical Genetics, 2009
- Role of mitofusin 2 mutations in the physiopathology of Charcot–Marie–Tooth disease type 2AExperimental Neurology, 2009
- Adenine nucleotide translocase is involved in a mitochondrial coupling defect in MFN2-related Charcot–Marie–Tooth type 2A diseaseneurogenetics, 2009
- Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K)neurogenetics, 2008
- Mitochondrial coupling defect in Charcot–Marie–Tooth type 2A diseaseAnnals of Neurology, 2007
- Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial networkJournal of Cell Biology, 2005